These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 24968158)

  • 1. Modified Newcastle disease virus vectors expressing the H5 hemagglutinin induce enhanced protection against highly pathogenic H5N1 avian influenza virus in chickens.
    Kim SH; Paldurai A; Xiao S; Collins PL; Samal SK
    Vaccine; 2014 Jul; 32(35):4428-4435. PubMed ID: 24968158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunization of chickens with Newcastle disease virus expressing H5 hemagglutinin protects against highly pathogenic H5N1 avian influenza viruses.
    Nayak B; Rout SN; Kumar S; Khalil MS; Fouda MM; Ahmed LE; Earhart KC; Perez DR; Collins PL; Samal SK
    PLoS One; 2009 Aug; 4(8):e6509. PubMed ID: 19654873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterologous prime-boost immunization of Newcastle disease virus vectored vaccines protected broiler chickens against highly pathogenic avian influenza and Newcastle disease viruses.
    Kim SH; Samal SK
    Vaccine; 2017 Jul; 35(33):4133-4139. PubMed ID: 28668574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Level of protection of chickens against highly pathogenic H5 avian influenza virus with Newcastle disease virus based live attenuated vector vaccine depends on homology of H5 sequence between vaccine and challenge virus.
    Römer-Oberdörfer A; Veits J; Helferich D; Mettenleiter TC
    Vaccine; 2008 May; 26(19):2307-13. PubMed ID: 18395947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A recombinant avian paramyxovirus serotype 3 expressing the hemagglutinin protein protects chickens against H5N1 highly pathogenic avian influenza virus challenge.
    Shirvani E; Varghese BP; Paldurai A; Samal SK
    Sci Rep; 2020 Feb; 10(1):2221. PubMed ID: 32042001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective efficacy of Newcastle disease virus expressing soluble trimeric hemagglutinin against highly pathogenic H5N1 influenza in chickens and mice.
    Cornelissen LA; de Leeuw OS; Tacken MG; Klos HC; de Vries RP; de Boer-Luijtze EA; van Zoelen-Bos DJ; Rigter A; Rottier PJ; Moormann RJ; de Haan CA
    PLoS One; 2012; 7(8):e44447. PubMed ID: 22952980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Newcastle disease virus vectors expressing consensus sequence of the H7 HA protein protect broiler chickens and turkeys against highly pathogenic H7N8 virus.
    Roy Chowdhury I; Yeddula SGR; Pierce BG; Samal SK; Kim SH
    Vaccine; 2019 Aug; 37(35):4956-4962. PubMed ID: 31320218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal antibody inhibition of recombinant Newcastle disease virus vectored vaccine in a primary or booster avian influenza vaccination program of broiler chickens.
    Bertran K; Lee DH; Criado MF; Balzli CL; Killmaster LF; Kapczynski DR; Swayne DE
    Vaccine; 2018 Oct; 36(43):6361-6372. PubMed ID: 30241684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection of chickens against H5N1 highly pathogenic avian influenza virus infection by live vaccination with infectious laryngotracheitis virus recombinants expressing H5 hemagglutinin and N1 neuraminidase.
    Pavlova SP; Veits J; Keil GM; Mettenleiter TC; Fuchs W
    Vaccine; 2009 Jan; 27(5):773-85. PubMed ID: 19041677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Newcastle disease virus-based live attenuated vaccine completely protects chickens and mice from lethal challenge of homologous and heterologous H5N1 avian influenza viruses.
    Ge J; Deng G; Wen Z; Tian G; Wang Y; Shi J; Wang X; Li Y; Hu S; Jiang Y; Yang C; Yu K; Bu Z; Chen H
    J Virol; 2007 Jan; 81(1):150-8. PubMed ID: 17050610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccine protection of chickens against antigenically diverse H5 highly pathogenic avian influenza isolates with a live HVT vector vaccine expressing the influenza hemagglutinin gene derived from a clade 2.2 avian influenza virus.
    Kapczynski DR; Esaki M; Dorsey KM; Jiang H; Jackwood M; Moraes M; Gardin Y
    Vaccine; 2015 Feb; 33(9):1197-205. PubMed ID: 25613723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction of a recombinant duck enteritis virus (DEV) expressing hemagglutinin of H5N1 avian influenza virus based on an infectious clone of DEV vaccine strain and evaluation of its efficacy in ducks and chickens.
    Wang J; Ge A; Xu M; Wang Z; Qiao Y; Gu Y; Liu C; Liu Y; Hou J
    Virol J; 2015 Aug; 12():126. PubMed ID: 26263920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of live and inactivated recombinant Newcastle disease virus vaccines expressing clade 2.3.4.4b H5 hemagglutinin against H5N1 highly pathogenic avian influenza in SPF chickens, Broilers, and domestic ducks.
    Kim DH; Lee SH; Kim J; Lee J; Jeong JH; Kim JY; Song SU; Lee H; Cho AY; Hyeon JY; Youk S; Song CS
    Vaccine; 2024 Jul; 42(18):3756-3767. PubMed ID: 38724417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innovation in Newcastle Disease Virus Vectored Avian Influenza Vaccines.
    Kim SH; Samal SK
    Viruses; 2019 Mar; 11(3):. PubMed ID: 30917500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel chimeric Newcastle disease virus vectored vaccine against highly pathogenic avian influenza virus.
    Kim SH; Paldurai A; Samal SK
    Virology; 2017 Mar; 503():31-36. PubMed ID: 28110247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Newcastle disease virus-vectored vaccines expressing the hemagglutinin or neuraminidase protein of H5N1 highly pathogenic avian influenza virus protect against virus challenge in monkeys.
    DiNapoli JM; Nayak B; Yang L; Finneyfrock BW; Cook A; Andersen H; Torres-Velez F; Murphy BR; Samal SK; Collins PL; Bukreyev A
    J Virol; 2010 Feb; 84(3):1489-503. PubMed ID: 19923177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Newcastle Disease Virus-Vectored H7 and H5 Live Vaccines Protect Chickens from Challenge with H7N9 or H5N1 Avian Influenza Viruses.
    Liu Q; Mena I; Ma J; Bawa B; Krammer F; Lyoo YS; Lang Y; Morozov I; Mahardika GN; Ma W; García-Sastre A; Richt JA
    J Virol; 2015 Jul; 89(14):7401-8. PubMed ID: 25926639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coexpression of avian influenza virus H5 and N1 by recombinant Newcastle disease virus and the impact on immune response in chickens.
    Ramp K; Veits J; Deckers D; Rudolf M; Grund C; Mettenleiter TC; Römer-Oberdörfer A
    Avian Dis; 2011 Sep; 55(3):413-21. PubMed ID: 22017039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of H5 hemagglutinin vaccine antigen in common duckweed (Lemna minor) protects against H5N1 high pathogenicity avian influenza virus challenge in immunized chickens.
    Bertran K; Thomas C; Guo X; Bublot M; Pritchard N; Regan JT; Cox KM; Gasdaska JR; Dickey LF; Kapczynski DR; Swayne DE
    Vaccine; 2015 Jul; 33(30):3456-62. PubMed ID: 26067184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of thermostable Newcastle disease virus recombinants expressing the hemagglutinin of H5N1 avian influenza virus as bivalent vaccine candidates.
    Xu L; Qin Z; Qiao L; Wen J; Shao H; Wen G; Pan Z
    Vaccine; 2020 Feb; 38(7):1690-1699. PubMed ID: 31937412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.